Efficient genome editing in pathogenic mycobacteria using Streptococcus thermophilus CRISPR1-Cas9 - 30/09/20
Abstract |
The ability to genetically engineer pathogenic mycobacteria has increased significantly over the last decades due to the generation of new molecular tools. Recently, the application of the Streptococcus pyogenes and the Streptococcus thermophilus CRISPR‐Cas9 systems in mycobacteria has enabled gene editing and efficient CRISPR interference‐mediated transcriptional regulation. Here, we converted CRISPR interference into an efficient genome editing tool for mycobacteria. We demonstrate that the Streptococcus thermophilus CRISPR1-Cas9 (Sth1Cas9) is functional in Mycobacterium marinum and Mycobacterium tuberculosis, enabling highly efficient and precise DNA breaks and indel formation, without any off-target effects. In addition, with dual sgRNAs this system can be used to generate two indels simultaneously or to create specific deletions. The ability to use the power of the CRISPR-Cas9-mediated gene editing toolbox in M. tuberculosis with a single step will accelerate research into this deadly pathogen.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Efficient genome editing in Mycobacterium marinum and Mycobacterium tuberculosis. |
• | Efficient single-plasmid CRISPR-Cas9 system to induce specific genomic mutations. |
• | Dual sgRNA expression to facilitate targeted genomic deletions or multiple mutations. |
Keywords : CRISPR-Cas9 system, Genome editing, Indels, Mycobacterium marinum, Mycobacterium tuberculosis
Abbreviations : CRISPR, CRISPRi, Sth1Cas9, sgRNA, NHEJ, HR, ATc, indel, PAM, INH
Plan
Vol 124
Article 101983- septembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?